Fred Aslan
Chief Executive Officer, Director at Artiva Biotherapeutics, Inc. (ARTV)
Fred Aslan has filed 15 insider reports with the SEC since July 2024, as chief Executive Officer and director at Artiva Biotherapeutics, Inc. (ARTV). In the last 12 months Fred Aslan sold $1.94M of stock on the open market. In the latest filing, on November 18, 2026, Fred Aslan sold 119,771 shares of Artiva Biotherapeutics, Inc. (ARTV) for $469K at an average of $3.91.
- Filings
- 15
- Companies
- 1
- Bought on market
- None
- Sold on market
- $2.18M
Companies where Fred Aslan is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Executive Officer, Director | 1,337,657 | $2.18M | $3.78 | Nov 18, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Nov 17, 2026-$469KARTVChief Executive Officer Fred Aslan sold $468,532 worth of shares (119,771 units at $3.91), decreasing direct ownership by 8% to 1,337,657 units (withholding tax)Form 4Open-market sale
- Nov 2, 2026-$260KARTVChief Executive Officer Aslan Fred sold $259,972 worth of shares (62,178 units at $4.18), decreasing direct ownership by 4% to 1,457,428 units to satisfy tax liabilityForm 4Open-market sale
- Sep 15, 2026ARTVChief Executive Officer Aslan Fred was granted 110,000 shares, increasing direct ownership by 7% to 1,604,765 unitsForm 4Grant or award
- Sep 10, 2026ARTVChief Executive Officer Aslan Fred was granted 45,000 shares, increasing direct ownership by 3% to 1,494,765 unitsForm 4Grant or award
- Sep 8, 2026-$256KARTVChief Executive Officer Aslan Fred sold $255,746 worth of shares (23,429 units at $10.92) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 1,449,765 unitsForm 4Open-market sale10b5-1 plan
- Sep 3, 2026-$690KARTVChief Executive Officer Aslan Fred sold $690,392 worth of shares (61,888 units at $11.16), decreasing direct ownership by 4% to 1,473,194 units (tax liability)Form 4Open-market sale
- May 19, 2026-$244KARTVChief Executive Officer Aslan Fred sold $244,253 worth of shares (27,116 units at $9.01), decreasing direct ownership by 2% to 1,535,082 units (withholding tax)Form 4Open-market sale
- Feb 15, 2026ARTVPresident and CEO Aslan Fred was granted 366,850 shares and covered exercise/tax liability with 14,600 shares, increasing direct ownership by 29% to 1,562,198 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Dec 15, 2025-$19.1KARTVPresident and CEO Aslan Fred sold $19,122 worth of shares (3,187 units at $6.00), decreasing direct ownership by 0.26% to 1,209,948 unitsForm 4Open-market sale10b5-1 plan
- Dec 12, 2025ARTVPresident and CEO Aslan Fred was granted 869,136 shares, increasing direct ownership by 253% to 1,213,135 unitsForm 4Grant or awardSale back to the company
- Nov 17, 2025-$21.5KARTVPresident and CEO Aslan Fred sold $21,522 worth of shares (6,375 units at $3.38) and covered exercise/tax liability with 6,347 shares, decreasing direct ownership by 4% to 343,999 unitsForm 4Shares withheld for taxes or exercise priceOpen-market sale10b5-1 plan
- Oct 17, 2025-$153KARTVPresident and CEO Aslan Fred sold $153,000 worth of shares (25,500 units at $6.00), decreasing direct ownership by 7% to 356,721 unitsForm 4Open-market sale10b5-1 plan
- Aug 15, 2025-$69.6KARTVPresident and CEO Aslan Fred covered exercise/tax liability with 8,944 shares and sold $69,579 worth of shares (25,500 units at $2.73), decreasing direct ownership by 8% to 382,221 unitsForm 4Shares withheld for taxes or exercise priceOpen-market sale10b5-1 plan
- Mar 5, 2025ARTVPresident and CEO Aslan Fred was granted 200,000 shares, increasing direct ownership by 92% to 416,665 unitsForm 4Grant or award
- Jul 22, 2024ARTVPresident and CEO Aslan Fred was granted 228,905 sharesForm 4Grant or award
Compare Fred Aslan with
- Fred Aslan vs Gines Diego Miralles1 shared
- Fred Aslan vs Christopher Horan1 shared
- Fred Aslan vs Jennifer Bush1 shared
- Fred Aslan vs Subhashis Banerjee1 shared
- Fred Aslan vs Laura Stoppel1 shared
- Fred Aslan vs Elizabeth L Hougen1 shared
Other insiders at the same companies
- Gines Diego MirallesARTV
- Christopher HoranARTV
- Jennifer BushARTV
- Subhashis BanerjeeARTV
- Ra Capital Management, L.P.ARTV
- Laura StoppelARTV
- Elizabeth L HougenARTV
- Elaine K. SorgARTV
- Daniel G. BakerARTV
- Brian DanielsARTV
- Alison MooreARTV
- GC Corp.ARTV
- Heather RaymonARTV
- Thad Allen HustonARTV
- Neha KrishnamohanARTV
- Thorsten GraefARTV
Questions about Fred Aslan
- What is Fred Aslan's role at Artiva Biotherapeutics, Inc.?
- Fred Aslan reports to the SEC as chief Executive Officer and director at Artiva Biotherapeutics, Inc. (ARTV), according to the latest filing on November 18, 2026.
- How many shares does Fred Aslan own?
- After the latest filing that states it, Fred Aslan directly owned 1,337,657 shares of Artiva Biotherapeutics, Inc. (ARTV). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Fred Aslan bought or sold stock recently?
- The most recent open-market sale was on November 17, 2026: sold 119,771 shares of Artiva Biotherapeutics, Inc. (ARTV) for $469K at an average of $3.91.
- How do I get alerts when Fred Aslan files?
- Follow Fred Aslan on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Fred Aslan filed 6 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Fred Aslan (SEC CIK 0001909362). Totals count each trade once, skipping amendments whose original is on file, from Jul 23, 2024 on. View on SEC EDGAR · Get this as JSON